金隅集團(02009.HK)斥1億元參與投資設立北京金海誠科創投資合夥企業
格隆匯7月29日丨金隅集團(02009.HK)發佈公吿,為契合首都“四個中心”功能定位中的國際科技創新中心建設需求,升級和完善金隅產業園區運營服務體系,打造創新創業生態,助推園區轉型發展,公司全資的所屬公司北京金隅科技創新有限公司以自有資金人民幣1億元參與投資設立北京金海誠科創投資合夥企業(有限合夥)。
基金主要投資領域:重點圍繞5G與物聯網、量子通信技術、人工智能與大數據、新能源與新材料、集成電路芯片設計、創新生物藥和高端醫療器械等領域進行項目和子基金投資。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.